TY - JOUR
T1 - Auto-assembling detoxified staphylococcus aureus alpha-hemolysin mimicking the wild-type cytolytic toxin
AU - Fiaschi, Luigi
AU - Di Palo, Benedetta
AU - Scarselli, Maria
AU - Pozzi, Clarissa
AU - Tomaszewski, Kelly
AU - Galletti, Bruno
AU - Nardi-Dei, Vincenzo
AU - Arcidiacono, Letizia
AU - Mishra, Ravi P.N.
AU - Mori, Elena
AU - Pallaoro, Michele
AU - Falugi, Fabiana
AU - Torre, Antonina
AU - Fontana, Maria Rita
AU - Soriani, Marco
AU - Wardenburg, Juliane Bubeck
AU - Grandi, Guido
AU - Rappuoli, Rino
AU - Ferlenghi, Ilaria
AU - Bagnoli, Fabio
N1 - Publisher Copyright:
Copyright © 2016 Fiaschi et al.
PY - 2016/6
Y1 - 2016/6
N2 - Staphylococcus aureus alpha-hemolysin (Hla) assembles into heptameric pores on the host cell membrane, causing lysis, apoptosis, and junction disruption. Herein, we present the design of a newly engineered S. aureus alpha-toxin, HlaPSGS, which lacks the predicted membrane-spanning stem domain. This protein is able to form heptamers in aqueous solution in the absence of lipophilic substrata, and its structure, obtained by transmission electron microscopy and single-particle reconstruction analysis, resembles the cap of the wild-type cytolytic Hla pore. HlaPSGS was found to be impaired in binding to host cells and to its receptor ADAM10 and to lack hemolytic and cytotoxic activity. Immunological studies using human sera as well as sera from mice convalescent from S. aureus infection suggested that the heptameric conformation of HlaPSGS mimics epitopes exposed by the cytolytic Hla pore during infection. Finally, immunization with this newly engineered Hla generated high protective immunity against staphylococcal infection in mice. Overall, this study provides unprecedented data on the natural immune response against Hla and suggests that the heptameric HlaPSGS is a highly valuable vaccine candidate against S. aureus.
AB - Staphylococcus aureus alpha-hemolysin (Hla) assembles into heptameric pores on the host cell membrane, causing lysis, apoptosis, and junction disruption. Herein, we present the design of a newly engineered S. aureus alpha-toxin, HlaPSGS, which lacks the predicted membrane-spanning stem domain. This protein is able to form heptamers in aqueous solution in the absence of lipophilic substrata, and its structure, obtained by transmission electron microscopy and single-particle reconstruction analysis, resembles the cap of the wild-type cytolytic Hla pore. HlaPSGS was found to be impaired in binding to host cells and to its receptor ADAM10 and to lack hemolytic and cytotoxic activity. Immunological studies using human sera as well as sera from mice convalescent from S. aureus infection suggested that the heptameric conformation of HlaPSGS mimics epitopes exposed by the cytolytic Hla pore during infection. Finally, immunization with this newly engineered Hla generated high protective immunity against staphylococcal infection in mice. Overall, this study provides unprecedented data on the natural immune response against Hla and suggests that the heptameric HlaPSGS is a highly valuable vaccine candidate against S. aureus.
UR - http://www.scopus.com/inward/record.url?scp=84973472596&partnerID=8YFLogxK
U2 - 10.1128/CVI.00091-16
DO - 10.1128/CVI.00091-16
M3 - Article
C2 - 27030589
AN - SCOPUS:84973472596
SN - 1556-6811
VL - 23
SP - 442
EP - 450
JO - Clinical and Vaccine Immunology
JF - Clinical and Vaccine Immunology
IS - 6
ER -